Apply generously to the entire affected area and areas at risk (face, forehead, ears, skull and back of hands) twice a day, in the morning and at midday.
Daily use. Photolyase is activated by visible light.
If exposed to direct sunlight, reapply every two hours.
Apply to clean, intact skin.
Do not apply any other dermatological or cosmetic product within 20 minutes of application.
For patients on medication or who have undergone surgery for actinic keratosis or non-melanoma skin cancer, start treatment after the lesions have disappeared Eryfotona after lesions have disappeared.
Its daily use is essential to prevent actinic keratosis and non-melanoma skin cancers in a coadjuvant way.
Actinic keratosis and other forms of non-melanoma skin cancer are diseases caused by chronic exposure to the sun.
If you suffer from actinic keratosis or non-melanoma skin cancer, we recommend that you avoid direct exposure to the sun.
We do not recommend its use for children, pregnant women or while breast-feeding.
Avoid contact with eyes and mucous membranes.
In the event of a possible adverse reaction to any of the ingredients, discontinue use and consult your doctor or dermatologist.
Keep out of sight and reach of children.
Shake bottle before use.
